- 期刊
Successful Treatment of Acute Hepatitis A-Associated Hemophagocytic Syndrome by Intravenous Immunoglobulin
以靜脈免疫球蛋白成功治療A型肝炎引起的噬血症候群
並列摘要
Virus associated hemophagocytic syndrome (VAHS) is a rare complication in acute hepatitis A virus (HAV) infection. There is no standard therapy for VAHS and the clinical course is variable. Data on the use of intravenous immunoglobulin (IVIG) in the treatment of HAV-associated VAHS is limited. We report a previously healthy, 32 year old man who presented with general malaise, fever, chills and splenomegaly. Laboratory examination showed marked elevation of aminotransferase, leukopenia and thrombocytopenia. Acute hepatitis A was documented by the presence of immunoglobulin M anti-HAV and compatible liver biopsy findings. Bone marrow examination revealed extensive hemophagocytosis. IVIG was administered after the diagnosis of HAV-associated VAHS. His symptoms and laboratory abnormalities improved, and following a smooth recovery he was discharged 1 month after admission.
延伸閱讀
- 陳金榮、何一芳、林嘉伯（1988）。免疫球蛋白製劑之B型肝炎表面抗原及抗人類免疫缺乏病毒抗體檢測。藥物食品檢驗局調查研究年報，()，74-81。https://doi.org/10.6946/ASRNL.198809.0074
- 周哲右（2011）。抗病毒藥物治療、Ｂ型肝炎病毒聚合脢基因序列變異、和肝細胞癌存活之初步分析〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2011.10595
- Horng, J. H. (2020). 基於HBV X蛋白之治療性疫苗於慢性B型肝炎病毒帶原小鼠之療效及相關免疫機轉研究 [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU202004254
- Liu, C. J., Gau, J. P., Liu, J. H., Hsu, H. C., & Tzeng, C. H. (2010). B型肝炎表面抗原陰性抗體陽性之病人異體造血幹細胞移植後潛伏感染的B型肝炎再活化：淋巴性癌症病人為高危險群應接受先制抗病毒治療. 台灣癌症醫學雜誌, 26(5), 21-25. https://doi.org/10.6323/JoCRP.2010.26.5.4
- 廖浤鈞、劉士任（2019）。免疫療法：治癒慢性B型肝炎的新契機。感染控制雜誌，29(4)，200-208。https://doi.org/10.6526/ICJ.201908_29(4).0005